Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04773301
Status:
COMPLETED
Last Update Posted:
2021-03-03
First Post:
2021-02-15
Brief Title:
Comparative Study Between Levobupivacaine and Ropivacaine in the Hip Fractures of the Elderly
Sponsor:
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Organization:
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Study Overview
Official Title:
Randomized and Controlled Phase IV Clinical Trial on the Analgesic Effectiveness of the Combined Blockade in the Hip Fractures of the Elderly Comparative Study Between Levobupivacaine and Ropivacaine
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Prospective low-level non-commercial intervention comparative clinical trial phase IV of balanced randomized groups to compare the analgesic efficacy of the local anesthetics Ropivacaine and Levobupivacaine in peripheral nerve block in hip fracture surgery in the elderly
Detailed Description:
There are several studies that try to identify the ideal anesthetic for the management and control of pain in hip fracture surgery in the elderly The optimum would be to use an anesthetic with the lowest possible latency since this will favor the start of surgery And at the same time with a more lasting analgesia with the least motor impairment Therefore it is essential to collect data on efficacy effective block that allows us to mobilize the patient latency and analgesic scales appropriate to the cognitive state of the study sample
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None